Trademark Search in Canada

TFINITY

View On IC.GC.CA

REGISTERED

on 20 Apr 2020

Last Applicant/ Owned by

FATE THERAPEUTICS INC. A DELAWARE CORPORATION

3535 General Atomics Court, Suite 200San Diego, CA 92121

Serial Number

1823646 filed on 20^th Feb 2017

Registration Number

TMA1076992 registered on 20^th Apr 2020

Registration expiry Date

20^th Apr 2030

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

V6C2B5

TFINITY

Trademark usage description

cells and pharmaceutical preparations for the treatment of diseases, namely hematopoietic cells for medical purposes; hematopoietic cell preparation f Read More

Classification Information

Class [005]
Cells and pharmaceutical preparations for the treatment of diseases, namely hematopoietic cells for medical purposes; hematopoietic cell preparation for the treatment of disease and immune disorders, namely cancer and autoimmune disorders; therapeutic agents, namely hematopoietic cell preparations for use as immunotherapies in the prevention and treatment of cancer; pharmaceutical preparations for the treatment of disease, namely cancer and autoimmune disorders; kits comprised of cells and pharmaceutical preparations for the treatment of cancer and autoimmune disease; bio-engineered component for a therapeutic material, namely cell lines used for immunotherapy in the treatment and prevention of cancer and autoimmune disease

Classification kind code

Mark Details

Serial Number

1823646

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 7^th Aug 2019	Advertised
Submitted for opposition 26 on 16^th Jul 2019	Approved
Submitted for opposition 27 on 16^th Jul 2019	Approval Notice Sent
Submitted for opposition 15 on 10^th Jan 2019	Correspondence Created
Submitted for opposition 12 on 27^th Jun 2018	Extension of Time
Submitted for opposition 22 on 19^th Dec 2017	Search Recorded
Submitted for opposition 20 on 19^th Dec 2017	Examiner's First Report
Submitted for opposition 31 on 22^nd Feb 2017	Formalized
Submitted for opposition 1 on 21^st Feb 2017	Created
Submitted for opposition 30 on 20^th Feb 2017	Filed